Calliditas Therapeutics A...

NASDAQ: CALT · Real-Time Price · USD
40.00
-0.04 (-0.10%)
At close: Sep 20, 2024, 10:00 PM

Calliditas Therapeutics AB (publ) Cash Flow Statement

Financials in SEK. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-466.19M -421.94M -524.46M
Depreciation & Amortization
16.59M 12.91M 34.43M
Stock-Based Compensation
52.59M 35.79M 21.96M
Other Working Capital
-79.74M 183.06M 18.13M
Other Non-Cash Items
207.61M -26.54M 66.68M
Deferred Income Tax
n/a n/a -65.67M
Change in Working Capital
-79.74M 88.42M 5.47M
Operating Cash Flow
-434.65M -311.35M -461.59M
Capital Expenditures
-12.79M -2.51M -22.65M
Cash Acquisitions
n/a n/a -47.02M
Purchase of Investments
-1.56M -2.63M -1.69M
Sales Maturities Of Investments
602K n/a 71.36M
Other Investing Acitivies
1K 1K -24.34M
Investing Cash Flow
-13.74M -5.14M -24.34M
Debt Repayment
226.28M 482.13M 193.95M
Common Stock Repurchased
n/a -236K n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
-26.63M 93.86M -82.79M
Financial Cash Flow
199.65M 575.99M 435.16M
Net Cash Flow
-275.36M 293.59M -40.8M
Free Cash Flow
-447.44M -313.87M -484.24M